Benzinga | Jul 29, 2021 08:12AM EDT

Canaccord Genuity Downgrades Theratechnologies to Hold, Lowers Price Target to $3

Canaccord Genuity analyst Edward Nash downgrades Theratechnologies (NASDAQ:THTX) from Buy to Hold and lowers the price target from $8 to $3.